<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">EXCLI J</journal-id>
      <journal-title>EXCLI Journal</journal-title>
      <issn pub-type="epub">1611-2156</issn>
      <publisher>
        <publisher-name>Leibniz Research Centre for Working Environment and Human Factors</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">2013-199</article-id>
      <article-id pub-id-type="pii">Doc523</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Evaluation of chromosome aberrations induced by digoxin in Chinese hamster ovary cells</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sedigh-Ardekani</surname>
            <given-names>Mozhgan</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saadat</surname>
            <given-names>Iraj</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saadat</surname>
            <given-names>Mostafa</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1">&#x0002a;</xref>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>Department of Biology, College of Sciences, Shiraz University, Shiraz 71454, Iran and Institute of Biotechnology, Shiraz University, Shiraz, Iran</aff>
      <author-notes>
        <corresp id="COR1">*To whom correspondence should be addressed: Mostafa Saadat, Department of Biology, College of Sciences, Shiraz University, Shiraz 71454, Iran and Institute of Biotechnology, Shiraz University, Shiraz, Iran; Fax: +98-711-2280926, E-mail: <email>saadat@shirazu.ac.ir and msaadat41@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>06</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <volume>12</volume>
      <fpage>523</fpage>
	  <lpage>527</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>03</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>06</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Sedigh-Ardekani et al.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://www.excli.de/documents/assignment_of_rights.pdf">
		<p>This is an Open Access article distributed under the following Assignment of Rights http://www.excli.de/documents/assignment_of_rights.pdf. You are free to copy, distribute and transmit the work, provided the original author and source are credited.</p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.excli.de/vol12/Saadat_04062013_proof.pdf">This article is available from http://www.excli.de/vol12/Saadat_04062013_proof.pdf</self-uri>
      <abstract><p>Digoxin is a cardiac glycoside that has been reported to inhibit growth of multiple tumor cell types in vitro. The present study was assessing the cytogenetic effects of this drug on Chinese Hamster Ovary (CHO) cells. All experiments were performed in triplicate. The IC<sub>50</sub> was 22.5 &#xB1; 0.8 &#xB5;g&#x2F;ml. To investigate the clastogenic effects of drug, chromosomal aberration in metaphase cells were analyzed. Chromatid breaks and polyploidy were the main types of aberration. Mitomycin-C and sodium arsenite were used as positive controls. CHO cells were exposed to different concentration of drug (5, 10, 15, 20 &#xB5;g&#x2F;ml) in 24 hours. All of the study aberrations and frequency of aberrant cells significantly increased as a function of digoxin concentration (for chromatid breaks: r &#x3D; 0.881, df &#x3D; 13, P &#x3C; 0.001; for polyploidy: r &#x3D; 0.777, df &#x3D; 13, P &#x3D; 0.001; for cells with aberrations: r &#x3D; 0.926, df &#x3D; 13, P &#x3C; 0.001). The mitotic index negatively correlated with the concentration of digoxin (r &#x3D; -0.978, df &#x3D; 13, P &#x3C; 0.001). All concentrations that cause chromosomal aberrations are in the cytotoxic range of the drug. The peak serum digoxin concentration (5 - 20 ng&#x2F;ml) was very lower than concentrations we used in the present experiments. Further studies on valuation of chromatid breaks, micronuclei, and sister chromatid exchange in lymphocytes of patients who received digoxin, were recommended.</p></abstract>
      <kwd-group>
        <kwd>digoxin</kwd>
        <kwd>chromatid breakage</kwd>
        <kwd>mitotic index</kwd>
        <kwd>polyploidy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title><p>Digoxin is a purified cardiac glycoside extracted from the foxglove plant, <italic>Digitalis lanata</italic>. Digoxin is widely used in the treatment of various heart conditions, namely artial fibrillation, artial flutter and sometimes heart failure that cannot be controlled by other medication (Chao et al., 1992[<xref ref-type="bibr" rid="R2">2</xref>]). Digoxin preparations are commonly marketed under the trade names, such as Lanoxin.</p><p>Several epidemiological studies indicated that breast cancer cells obtained from women on digitalis therapy (for congestive heart failure) were characterized by a series of more benign features compared with cancer cells from control patients (Stenkvist 1999[<xref ref-type="bibr" rid="R17">17</xref>]; Stenkvist et al., 1979[<xref ref-type="bibr" rid="R19">19</xref>], 1980[<xref ref-type="bibr" rid="R18">18</xref>], 1982[<xref ref-type="bibr" rid="R20">20</xref>]; Goldin &#x26; Safa 1984[<xref ref-type="bibr" rid="R3">3</xref>]). The growth inhibitory effects of cardiac glycosides such as digoxin in the several cancer cell lines have been reported (Haux 1999[<xref ref-type="bibr" rid="R4">4</xref>]; Johansson et al., 2001[<xref ref-type="bibr" rid="R5">5</xref>]; Lindholm et al., 2002[<xref ref-type="bibr" rid="R7">7</xref>]; L&#xF3;pez-L&#xE1;zaro et al., 2005[<xref ref-type="bibr" rid="R9">9</xref>]; Svensson et al., 2005[<xref ref-type="bibr" rid="R22">22</xref>]; Prassas and Diamandis 2008[<xref ref-type="bibr" rid="R14">14</xref>]). Taken together, it is very probable that digoxin has effect(s) on DNA and chromosomes. </p><p>Considering that there is no published data about effect of digoxin on induction of chromosomal aberrations, the present study was carried out. The aim of the present study was to assess the effect of digoxin on chromatid and chromosomal aberrations on Chinese hamster ovary (CHO) cells.</p></sec>
    <sec sec-type="materials|methods">
      <title>Material and Methods</title><sec><title>Cell culture and chromosome study</title><p>In the present study, experiments were carried out using the Chinese hamster ovary (CHO) cell line. The cells were maintained in RPMI-1640 medium (from GIBCO) supplemented with 10&#x25; inactivated fetal calf serum (from GIBCO), 2 mM L-glutamine and with the addition of penicillin (100 U&#x2F;ml) and stereptomycin (100 mg&#x2F;ml). For the present experiment we used Lanoxin (a trade name of digoxin, a liquid form, 0.25 mg&#x2F;ml; KERN Company). </p><p>Cells were seeded into 96-well plates at 2 &#xD7; 10<sup>4 </sup>cells&#x2F;well in 100 &#xB5;l complete medium. After the cells clung to plates, the cells were treated with various concentration of digoxin (2.5, 5, 10, 15, 20, 25, 30, 35 &#xB5;g&#x2F;ml) for 24 h. Final volume in each well was 200 &#xB5;l. Subsequently, the cell viability was measured by MTT dye reduction assay (Mosmann, 1983[<xref ref-type="bibr" rid="R13">13</xref>]; Liu et al., 1997[<xref ref-type="bibr" rid="R8">8</xref>]). The formazan dye was measured by ELISA reader. After obtaining the absorption, percentage inhibition of cell growth was calculated. The IC<sub>50</sub> is defined as the cytotoxicity index that reduces the cell number to 50 &#x25; compared with untreated-control CHO cells. </p><p>Mitomycin-C (0.06 &#xB5;g&#x2F;ml) and sodium arsenite (1 &#xB5;gM) were used as positive controls (Mahata et al., 2004[<xref ref-type="bibr" rid="R10">10</xref>]; Celikler et al., 2008[<xref ref-type="bibr" rid="R1">1</xref>]; Samuel et al., 2011[<xref ref-type="bibr" rid="R15">15</xref>]; Sulaiman, 2012[<xref ref-type="bibr" rid="R21">21</xref>]; Sedigh-Ardakani et al., 2013[<xref ref-type="bibr" rid="R16">16</xref>]). The CHO cells were seeded at the density of 1.8  &#xD7; 10<sup>6</sup> cells&#x2F;petridish in the volume of 10 ml. After 48 h, the cells were treated with different doses of digoxin (5, 10, 15 and 20 &#xB5;g&#x2F;ml) in RPMI-1640 for 24 h. Chromosomes were conventionally stained with Giemsa. </p><p>The metaphases were analyzed for the numbers and types of chromosome aberrations. Chromosome aberrations were classified to chromatid breaks and polyploidy. To determine the mitotic index (percentage of cells in mitosis), 1000 cells in each slide were observed. In each slide, 100 mitotic cells were counted to determine the chromosome aberrations. </p><p>All experiments (for determining either cytotoxiciy or chromosomal breakage) were performed in triplicate.</p></sec><sec><title>Statistical analysis</title><p>The level of the chromatid and chromosome breaks and also polyploidy, cells with aberrations and mitotic index are presented as mean <underline>&#x2B;</underline> standard deviation (SD). Comparisons of the mean values of the studied indices were done using one way analysis of variance. We used Duncan test as a Post hoc test. </p><p>Statistical analysis was performed using SPSS statistical software package (version 11.5) for windows (SPSS Inc., Chicago, IL, USA). A probability of P &#x3C; 0.05 was considered statistically significant. All P-values were two-tailed.</p></sec></sec>
    <sec sec-type="discussion">
      <title>Result and Discussion</title><p>Effect of digoxin on proliferation of CHO cells was investigated. After 24 h treatment of CHO cells with 2.5, 5, 10, 15, 20, 25, 30, 35 &#x3BD;g&#x2F;ml of digoxin, the percent of cell inhibition were 4.5, 9.4, 19.4, 28.3, 39.9, 60.8, 83, and 97, respectively (Figure 1<xref ref-type="fig" rid="F1">(Fig. 1)</xref>). Percent of growth inhibition rate increased as a function of digoxin concentration (r &#x3D; -0.980, df &#x3D; 25, P &#x3C; 0.001). The IC<sub>50</sub> for digoxin was estimated 22.5 &#xB1; 0.81 &#xB5;g&#x2F;ml. </p><p>The results of chromosome aberration test were presented in Table 1<xref ref-type="fig" rid="T1">(Tab. 1)</xref>. There were significant difference between positive controls and negative control for frequencies of chromatid breaks and polyploidy (For all comparisons P-values were less than 0.01). Digoxin at final concentration of 25 &#x3BD;g&#x2F;ml results very low metaphases, therefore, the analysis did not perform. All of the study aberrations and frequency of aberrant cells significantly increased as a function of digoxin concentration (for chromatid breaks: r &#x3D; 0.881, df &#x3D; 13, P &#x3C; 0.001; for polyploidy: r &#x3D; 0.777, df &#x3D; 13, P &#x3D; 0.001; for cells with aberrations: r &#x3D; 0.926, df &#x3D; 13, P &#x3C; 0.001). However, the mitotic index negatively correlated with the concentration of digoxin (r &#x3D; -0.978, df &#x3D; 13, P &#x3C; 0.001).</p><p>Based on more than a thousand published scientific articles, it is well established that using <italic>in vitro</italic> system, cardiac glycosides showed anti-cancer properties (Prassas and Diamandis, 2008[<xref ref-type="bibr" rid="R14">14</xref>]). Although the molecular mechanisms under lying the increased susceptibility to cancer cells to cardiac glycosides are not fully elucidated, some mechanisms such as alterations in homeostasis of K<sup>&#x2B;</sup>, Na<sup>&#x2B;</sup>, and Ca<sup>2&#x2B;</sup>, inhibition of tumor necroses factor and nuclear factor &#x3BB;B, increased production of reactive oxygen species, inhibition of toposiomerase II, etc, might be involved (McConkey et al., 2000[<xref ref-type="bibr" rid="R12">12</xref>]; Prassas and Diamandis, 2008[<xref ref-type="bibr" rid="R14">14</xref>]). Considering that digoxin increased the frequency of chromatid and chromosome breaks, it is suggested that digoxin may interact with DNA and subsequently inhibits cell division. The peak serum digoxin concentration (5-20 ng&#x2F;ml) was much lower than concentrations we used in the present experiments (Marcinkowska-Kr&#xF3;lewicz and Feldmann, 1998[<xref ref-type="bibr" rid="R11">11</xref>]; Tayrouz et al., 2003[<xref ref-type="bibr" rid="R23">23</xref>]; Kothare et al., 2005[<xref ref-type="bibr" rid="R6">6</xref>]). Based on the results of the present study, all concentrations that cause chromosomal aberrations are in the cytotoxic range of digoxin.</p><p>Tissue specific response to DNA and chromosomal damages due to drugs were reported. Therefore, it is possible that digoxin shows different patterns level of toxicity depended to cell type. On the other hand patients are exposed for longer periods compared to our cell culture system. Taken together, it is necessary to evaluate the chromatid breaks, micronuclei, and sister chromatid exchange in lymphocytes of patients who received digoxin. </p><p>Finally it should be mentioned that digoxin must be used cautiously in generally and particularly in children and pregnant women. Further experiments are necessary to clarify the significance of the present findings.</p></sec>
    <sec>
      <title>Acknowledgements</title><p>This study was supported by Shiraz University.</p></sec>
    <sec>
      <title>Disclosure Statement</title><p>No competing financial interests exist.</p></sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Celikler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yildiz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vatan</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Bilaloglu</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>In vitro antigenotoxicity of Ulva rigida C. Agardh (Chlorophyceae) extract against induction of chromosome aberration, sister chromatid exchange and micronuclei by mutagenic agent MMC</article-title>
          <source>Biomed Environ Sci</source>
          <year>2008</year>
          <volume>21</volume>
          <fpage>492</fpage>
          <lpage>498</lpage>
        </citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Chao</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>ESC</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Fetal atrial flutter and fibrillation: prenatal echocardiographic detection and management</article-title>
          <source>Am Heart J</source>
          <year>1992</year>
          <volume>124</volume>
          <fpage>1095</fpage>
          <lpage>1098</lpage>
        </citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Goldin</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Safa</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Digitalis and cancer</article-title>
          <source>Lancet</source>
          <year>1984</year>
          <volume>8386</volume>
          <fpage>1134</fpage>
        </citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Haux</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Digitoxin is a potential anticancer agent for several types of cancer</article-title>
          <source>Med Hypotheses</source>
          <year>1999</year>
          <volume>53</volume>
          <fpage>543</fpage>
          <lpage>548</lpage>
        </citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Johansson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lindholm</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gullbo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Larsson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bohlin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Claeson</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells</article-title>
          <source>Anticancer Drugs</source>
          <year>2001</year>
          <volume>12</volume>
          <fpage>475</fpage>
          <lpage>483</lpage>
        </citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Kothare</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Soon</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Linnebjerg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yeo</surname>
              <given-names>A</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Effect of exenatide on the steady-state pharmacokinetics of digoxin</article-title>
          <source>J Clin Pharmacol</source>
          <year>2005</year>
          <volume>45</volume>
          <fpage>1032</fpage>
          <lpage>1037</lpage>
        </citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Lindholm</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gullbo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Claeson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>G&#xF6;ransson</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Backlund</surname>
              <given-names>A</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Selective cytotoxicity evaluation in anticancer drug screening of fractionated plant extracts</article-title>
          <source>J Biomol Screen</source>
          <year>2002</year>
          <volume>7</volume>
          <fpage>333</fpage>
          <lpage>340</lpage>
        </citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Mechanism of cellular 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) reduction</article-title>
          <source>J Neurochem</source>
          <year>1997</year>
          <volume>69</volume>
          <fpage>581</fpage>
          <lpage>593</lpage>
        </citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>L&#xF3;pez-L&#xE1;zaro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pastor</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Azrak</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Ayuso</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Austin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Cort&#xE9;s</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients</article-title>
          <source>J Nat Prod</source>
          <year>2005</year>
          <volume>68</volume>
          <fpage>1642</fpage>
          <lpage>1645</lpage>
        </citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Mahata</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sarkar</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Ray</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Natarajan</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Giri</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Effect of sodium arsenite on peripheral lymphocytes in vitro: individual susceptibility among a population exposed to arsenic through the drinking water</article-title>
          <source>Mutagenesis</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>223</fpage>
          <lpage>229</lpage>
        </citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Marcinkowska-Kr&#xF3;lewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title xml:lang="de"></article-title>
          <trans-title>Can peak serum digoxin concentration be a sign of acute poisoning severity&#x3F; Analysis of two cases of digoxin poisoning</trans-title>
          <source>Pol Arch Med Wewn</source>
          <year>1998</year>
          <volume>100</volume>
          <fpage>344</fpage>
          <lpage>349</lpage>
        </citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>McConkey</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nutt</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Ozel</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Cardiac glycosides stimulate Ca2&#x2B; increases and apoptosis in androgen- independent, metastatic human prostate adenocarcinoma cells</article-title>
          <source>Cancer Res</source>
          <year>2000</year>
          <volume>60</volume>
          <fpage>3807</fpage>
          <lpage>3812</lpage>
        </citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Mosmann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</article-title>
          <source>J Immunol Meth</source>
          <year>1983</year>
          <volume>65</volume>
          <fpage>55–63</fpage>
        </citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Prassas</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Diamandis</surname>
              <given-names>EP</given-names>
            </name>
          </person-group>
          <article-title>Novel therapeutic applications of cardiac glycosides</article-title>
          <source>Nat Rev Drug Discov</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>926</fpage>
          <lpage>935</lpage>
        </citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Samuel</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Akande</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Ebuehi</surname>
              <given-names>OA</given-names>
            </name>
          </person-group>
          <article-title>Protective role of the methanolic extract of Icacina trichantha on sodium arsenite induced genotoxicity and hepatotoxicity</article-title>
          <source>Nig Q J Hosp Med</source>
          <year>2011</year>
          <volume>21</volume>
          <fpage>262</fpage>
          <lpage>266</lpage>
        </citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Sedigh-Ardakani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saadat</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Saadat</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Propranolol induced chromosomal aberrations in Chinese hamster ovary cell line</article-title>
          <source>Mol Biol Res Commun</source>
          <year>2013</year>
          <volume>2</volume>
          <fpage>11</fpage>
          <lpage>18</lpage>
        </citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Stenkvist</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Is digitalis a therapy for breast carcinoma&#x3F;</article-title>
          <source>Oncol Rep</source>
          <year>1999</year>
          <volume>6</volume>
          <fpage>493</fpage>
          <lpage>496</lpage>
        </citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Stenkvist</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bengtsson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eklund</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Holmquist</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nordin</surname>
              <given-names>B</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Evidence of a modifying influence of heart glucosides on the development of breast cancer</article-title>
          <source>Anal Quant Cytol</source>
          <year>1980</year>
          <volume>2</volume>
          <fpage>49</fpage>
          <lpage>54</lpage>
        </citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Stenkvist</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bengtsson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Holmquist</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nordin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Westman-Naeser</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cardiac glycosides and breast cancer</article-title>
          <source>Lancet</source>
          <year>1979</year>
          <volume>8115</volume>
          <fpage>563</fpage>
        </citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Stenkvist</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pengtsson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dahlqvist</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jarkrans</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nordin</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Cardiac glycosides and breast cancer, revisited</article-title>
          <source>N Engl J Med</source>
          <year>1982</year>
          <volume>306</volume>
          <fpage>484</fpage>
        </citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Sulaiman</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Role of caffeic acid phenethyl ester on mitomycin C induced clastogenesis: analysis of chromosome aberrations, micronucleus, mitotic index and adenosine deaminase activity in vivo</article-title>
          <source>J Appl Genet</source>
          <year>2012</year>
          <volume>53</volume>
          <fpage>213</fpage>
          <lpage>219</lpage>
        </citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Svensson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Azarbayjani</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>B&#xE4;ckman</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Christofferson</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Digoxin inhibits neuroblastoma tumor growth in mice</article-title>
          <source>Anticancer Res</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>207</fpage>
          <lpage>212</lpage>
        </citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Tayrouz</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Burhenne</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Riedel</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hoppe-Tichy</surname>
              <given-names>T</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40</article-title>
          <source>Clin Pharmacol Ther</source>
          <year>2003</year>
          <volume>73</volume>
          <fpage>397</fpage>
          <lpage>405</lpage>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="T1" position="float">
      <label>Table 1</label>
      <caption><title>Induction of chromatid breaks, polyploidy and mitotic index in CHO cells by digoxin</title></caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EXCLI-12-523-t-001" />
    </fig>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption><title>Effect of digoxin concentration on CHO cell line for 24 hours: The results are presented as percent of inhibition of cell growth obtained by MTT assay. Data are mean &#xB1; SD of triplicate cultures.</title></caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EXCLI-12-523-g-001" />
    </fig>
  </floats-wrap>
</article>